Spots Global Cancer Trial Database for Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
Official Title: An Open-Label, Randomized, Phase 3 Trial Of Intravenous Temsirolimus (CCI-779) At Two Dose Levels Compared To Investigator's Choice Therapy In Relapsed, Refractory Subjects With Mantle Cell Lymphoma (MCL)
Study ID: NCT00117598
Conditions
Study Description
Brief Summary: This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Little Rock, Arkansas, United States
Pfizer Investigational Site, Fountain Valley, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, New Milford, Connecticut, United States
Pfizer Investigational Site, Washington, District of Columbia, United States
Pfizer Investigational Site, Boca Raton, Florida, United States
Pfizer Investigational Site, Honolulu, Hawaii, United States
Pfizer Investigational Site, Chicago, Illinois, United States
Pfizer Investigational Site, Morristown, New Jersey, United States
Pfizer Investigational Site, Buffalo, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, Rochester, New York, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Upland, Pennsylvania, United States
Pfizer Investigational Site, Austin, Texas, United States
Pfizer Investigational Site, Grapevine, Texas, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Temple, Texas, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Buenos Aires, , Argentina
Pfizer Investigational Site, Buenos Aires, , Argentina
Pfizer Investigational Site, Cordoba, , Argentina
Pfizer Investigational Site, East Melbourne, Victoria, Australia
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Brugge, , Belgium
Pfizer Investigational Site, Gent, , Belgium
Pfizer Investigational Site, Leuven, , Belgium
Pfizer Investigational Site, Vila Buarque, Sao Paulo, Brazil
Pfizer Investigational Site, Porto Alegre - RS, , Brazil
Pfizer Investigational Site, Edmonton, Alberta, Canada
Pfizer Investigational Site, Vancouver, British Columbia, Canada
Pfizer Investigational Site, London, Ontario, Canada
Pfizer Investigational Site, Ottawa, Ontario, Canada
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Greenfield Park, Quebec, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Providencia, Santiago, Chile
Pfizer Investigational Site, Beijing, , China
Pfizer Investigational Site, Beijing, , China
Pfizer Investigational Site, Shanghai, , China
Pfizer Investigational Site, Shanghai, , China
Pfizer Investigational Site, Shanghai, , China
Pfizer Investigational Site, Lyon, , France
Pfizer Investigational Site, Paris Cedex 15, , France
Pfizer Investigational Site, Paris, , France
Pfizer Investigational Site, Pierre Benite, , France
Pfizer Investigational Site, Strasbourg, , France
Pfizer Investigational Site, Villejuif Cedex, , France
Pfizer Investigational Site, Ulm, BW, Germany
Pfizer Investigational Site, Ulm, BW, Germany
Pfizer Investigational Site, Heidelberg, , Germany
Pfizer Investigational Site, Mainz, , Germany
Pfizer Investigational Site, Bologna, , Italy
Pfizer Investigational Site, Catania, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Roma, , Italy
Pfizer Investigational Site, Rotterdam, , Netherlands
Pfizer Investigational Site, Lublin, , Poland
Pfizer Investigational Site, Warszawa, , Poland
Pfizer Investigational Site, L'Hospitalet de Llobregat, Barcelona, Spain
Pfizer Investigational Site, Pamplona, Navarra, Spain
Pfizer Investigational Site, Barcelona, , Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Lund, , Sweden
Pfizer Investigational Site, Uppsala, , Sweden
Pfizer Investigational Site, Aarau, , Switzerland
Pfizer Investigational Site, Plymouth, Devon, United Kingdom
Pfizer Investigational Site, Southampton, Hants, United Kingdom
Pfizer Investigational Site, Tooting, London, United Kingdom
Pfizer Investigational Site, Sutton, Surrey, United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
